Stents Market 2021 By Regional Statistics, CAGR, Trend & Growth Forecast To 2027

Stents Market 2021 By Regional Statistics, CAGR, Trend & Growth Forecast To 2027

With growing prevalence of cardiovascular disorders around the world and surging demand for enhanced techniques for disease treatment and surgeries, global stents market is set to witness enormous growth over the coming years. According to Global Market Insights, Inc., stents market size is estimated to surpass USD 14.3 billion by 2026.

Increasing adoption of unhealthy lifestyle is one of the major factors leading to increasing incidences of coronary artery diseases. This will evoke the usage of stents in the treatment of coronary artery disease thereby propelling the market growth.

Request for a sample copy of this report @  

Additionally, rigorous research activities for the development of advanced stent technologies will open new growth avenues for the business space. For instance, B. Braun and NuMED Inc. jointly developed a new stent delivery system named NuDEL™ CP Stent® in 2019 for treating various heart disorders. According to the company, this is a state-of-the-art product that combines three devices into single tool, which can provide physicians with higher procedural efficiency by eliminating the need of hand crimping a mounted stent into the introducer.

An overview of some of the major segments that are likely to augment the business outlook has been outlined below:

With regards to the product, vascular stents segment accounted for a revenue share of USD 10.3 billion in 2019 and is likely to witness significant growth in the subsequent years owing to ongoing technological advancements along with increasing number of patients with cardiovascular disorders (CVD). According to the European Heart Network, over 85 million people across the Europe are currently suffering from CVDs.

In terms of material bifurcation, Polymer stent segment is anticipated to register USD 3.0 billion by 2026 considering the massive usage of polyethylene, polyurethanes, polylactides and polyglycolides due to their biostable and biodegradable properties. In addition, various benefits associated with polymer stents such as high compatibility and minimum post-surgery complications, will complement the segment growth further.

In terms of product type, self-expandable stents segment is projected to register a valuation of USD 5.3 billion by 2026 on account of increasing product adoption owing to its ability to attain the required diameter after placement. Moreover, various benefits associated with self-expandable stents such as enhanced durability and excellent long-term patency rates is likely to impel the adoption of self-expandable stents further. Besides, these stents find important application for the treatment of patients suffering from femoropopliteal disease. For the records, the segment had accounted for a sizeable market share of 36.1% in 2019.

Request for customization @

Based on end-use, hospital segment had recorded an appreciable valuation of around USD 8.3 billion in the past and is expected to observe a steady growth over the following years. This can be credited to increased patient inclination towards these healthcare settings due to the availability of technologically advanced equipment and improved facilities. Further, strict implementation of guidelines in hospital settings provide enhanced patient safety and ensures better surgical outcomes which will foster the segment growth significantly.

Regionally, China stents market is projected to register a substantial CAGR of 5.5% through 2025 attributing to increasing prevalence of cardiovascular disorders in the country. Reportedly, 2 out of 5 deaths in China are a result of cardiovascular disease. Moreover, increasing inclination of market players toward  new product development will provide positive growth prospects for the industry in the near future.

Partial Chapter of the Table of Content

Chapter 2   Executive Summary

2.1    Stents industry 360° synopsis, 2015-2026

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Material trends

2.1.4    Type trends

2.1.5    End-use trends

2.1.6    Regional trends

Chapter 3   Stents Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2015 - 2026

3.3    Industry impact forces

3.3.1    Growth drivers    Growing cardiovascular disorders    Rising demand for minimally invasive procedures    Advancement in healthcare technology    Unhealthy and hectic lifestyle    Growing geriatric population

3.3.2    Industry pitfalls & challenges    Stent failure and recall    Stringent regulatory approvals

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By material

3.4.3    By type

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Porter's analysis

3.7    Competitive landscape, 2019

3.7.1    Company matrix analysis

3.8    PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @